Skip to content

Author

A. Vacca

We have 3 of 45 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Lipoprotein(a): a potential target for the reduction of residual cardiovascular risk in patients with chronic kidney disease

Epidemiological evidence demonstrates that atherosclerotic cardiovascular disease (ASCVD) is a major cause of death and disability in patients with chronic kidney disease (CKD). From the early stages of CKD, and in addition to specifically related conditions, the coexistence of traditional risk factors contributes to a...

Leonardo A. Sechi, Luca Bulfone, A. Vacca et al. · 0 citations

HFpEF in Asia Distinct Phenotypes, Shared Mechanisms, and Emerging Insights

Mechanistically, visceral adiposity, systemic inflammation, immunometabolic dysregulation, structural remodeling, and accelerated cardiac aging converge to drive HFpEF across Asian patients, often at lower body mass index thresholds than recognized in Western models.

E. Balasa, F. Capone, A. Vacca et al. · 0 citations
Review Open access Aug 2026

HFpEF in Asia: Distinct Phenotypes, Shared Mechanisms, and Emerging Insights.

Mechanistically, visceral adiposity, systemic inflammation, immunometabolic dysregulation, structural remodeling, and accelerated cardiac aging converge to drive HFpEF across Asian patients, often at lower body mass index thresholds than recognized in Western models.

E. Balasa, F. Capone, A. Vacca et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.